Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Corsini

Showing results (71-80 of 200) with videos related to

Pageof 20
Sort By:
Current Opinion in Lipidology|November 21, 2002
Safety considerations for statinsChiara Bolego, Roberta Baetta, Stefano Bellosta, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 10, 2015
Proprotein convertase subtilisin kexin type 9 and high-density lipoprotein metabolism: experimental animal models and clinical evidenceNicola Ferri, Alberto Corsini, Chiara Macchi, et al.
Clinical Chemistry and Laboratory Medicine|March 22, 2013
Gender medicine: a task for the third millenniumGiovannella Baggio, Alberto Corsini, Annarosa Floreani, et al.
Biochemical Pharmacology|November 1, 2005
Isothiazole dioxide derivative 6n inhibits vascular smooth muscle cell proliferation and protein farnesylationNicola Ferri, Francesca Clerici, Kohei Yokoyama, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 30, 2014
Aliskiren inhibits prorenin-induced human aortic smooth muscle cell migrationNicola Ferri, Federica Panariti, Chiara Ricci, et al.
Current Atherosclerosis Reports|July 28, 2022
Bempedoic Acid: for Whom and WhenMassimiliano Ruscica, Cesare R Sirtori, Stefano Carugo, et al.
European Journal of Clinical Investigation|February 14, 2021
Nonalcoholic fatty liver disease or metabolic dysfunction-associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approachesPaola Dongiovanni, Erika Paolini, Alberto Corsini, et al.
Current Atherosclerosis Reports|November 16, 2022
PCSK9 Inhibition and Risk of Diabetes: Should We Worry?Stefano Carugo, Cesare R Sirtori, Alberto Corsini, et al.
Pharmacological Research|May 24, 2020
Clinical approach to the inflammatory etiology of cardiovascular diseasesMassimiliano Ruscica, Alberto Corsini, Nicola Ferri, et al.
Cardiovascular Research|March 3, 2022
Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implicationsMassimiliano Ruscica, Nicola Ferri, Maciej Banach, et al.
Pageof 20

Showing results (71-80 of 200) with videos related to

Sort By:
Pageof 20
Current Opinion in Lipidology|November 21, 2002
Safety considerations for statinsChiara Bolego, Roberta Baetta, Stefano Bellosta, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 10, 2015
Proprotein convertase subtilisin kexin type 9 and high-density lipoprotein metabolism: experimental animal models and clinical evidenceNicola Ferri, Alberto Corsini, Chiara Macchi, et al.
Clinical Chemistry and Laboratory Medicine|March 22, 2013
Gender medicine: a task for the third millenniumGiovannella Baggio, Alberto Corsini, Annarosa Floreani, et al.
Biochemical Pharmacology|November 1, 2005
Isothiazole dioxide derivative 6n inhibits vascular smooth muscle cell proliferation and protein farnesylationNicola Ferri, Francesca Clerici, Kohei Yokoyama, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 30, 2014
Aliskiren inhibits prorenin-induced human aortic smooth muscle cell migrationNicola Ferri, Federica Panariti, Chiara Ricci, et al.
Current Atherosclerosis Reports|July 28, 2022
Bempedoic Acid: for Whom and WhenMassimiliano Ruscica, Cesare R Sirtori, Stefano Carugo, et al.
European Journal of Clinical Investigation|February 14, 2021
Nonalcoholic fatty liver disease or metabolic dysfunction-associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approachesPaola Dongiovanni, Erika Paolini, Alberto Corsini, et al.
Current Atherosclerosis Reports|November 16, 2022
PCSK9 Inhibition and Risk of Diabetes: Should We Worry?Stefano Carugo, Cesare R Sirtori, Alberto Corsini, et al.
Pharmacological Research|May 24, 2020
Clinical approach to the inflammatory etiology of cardiovascular diseasesMassimiliano Ruscica, Alberto Corsini, Nicola Ferri, et al.
Cardiovascular Research|March 3, 2022
Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implicationsMassimiliano Ruscica, Nicola Ferri, Maciej Banach, et al.
Pageof 20